Delhi HC allows Alembic, Natco to export Bayer cancer drug ingredient

Division bench says court will hear Bayer if the export by the two companies is done for purposes other than research

The Delhi High Court today allowed Alembic Pharmaceuticals and Natco Pharma to export sorafenib, an active ingredient in Bayer’s cancer drug Nexavar, and rivaroxaban, the active ingredient in its blood thinner medicine Xarelto for research and development purposes. A divison Bench of Justice S Ravindra Bhat and Justice Sanjeev Sachdeva, while agreeing with majority of the findings of a single judge bench allowing the exports, said that the question of whether those samples were being sent only for research and development or not will have to be heard afresh by the court.

Alembic refused to comments on the issue as they